|
|
|
|
|
|
|
|
|
21.08.25 - 23:45
|
Tariff-Driven Rally Reverses In Lumber Market (ZeroHedge)
|
|
Tariff-Driven Rally Reverses In Lumber Market
There is some good news in the lumber market: contracts have plunged more than 14% in recent weeks, reversing highs last seen during the pandemic shortages. The sharp reversal comes as bets on tariff-driven cost pressures and lower interest rates failed to lift demand. At the same time, disappointing housing data and weak earnings across the housing industry underscored the trouble festering.
Traders ramped up bets that U.S. tariffs on Canadian imports and lower interest rates would lift costs and demand, but housing activity has failed to deliver any demand tailwinds.
There has been weak builder confidence (hitting 13-year lows), disappointing housing permits, and earnings misses at Home Depot, James Hardie Industries, Builders FirstSource, and UFP Industries.
Earlier today...
Why is the housing market completely frozen? A new 30Y mortgage costs 6.80%. The average existing mortgage is almost 3% lower, or 4.11%. https://t.co/hOcBSnWZre pic...
|
|
|
|
|
|
20.08.25 - 16:42
|
Housing Market Cracks Widen: Top Siding Company Suffers Worst Stock Collapse In 50 Years (ZeroHedge)
|
|
Housing Market Cracks Widen: Top Siding Company Suffers Worst Stock Collapse In 50 Years
James Hardie Industries - the world's largest producer of fiber cement products, headquartered in Ireland and dual-listed in Sydney and New York - issued a grim housing outlook that sent its Sydney shares plunging the most in 50 years. The warning underscores deepening cracks emerging in the U.S. housing market under the continued weight of elevated interest rates. President Trump issued a new warning overnight about those rates "hurting" the housing industry.
James Hardie generates about 70% of its revenue from North America. Its flagship product, HardiePlank, is widely used in residential housing as an alternative to wood or vinyl siding. That makes the company's earnings reports closely watched, given its heavy exposure to the U.S. housing market.
Its first-quarter results missed Wall Street expectations, highlighting ongoing uncertainty in the housing market. Quarterly profit dropped to...
|
|
|
|
20.08.25 - 14:36
|
Santhera signs deal with Uniphar for GCC distribution of Agamree (PBR)
|
|
The therapy is intended for the treatment of Duchenne muscular dystrophy (DMD) in patients aged four years and above. Sales are projected to begin on a named patient
The post Santhera signs deal with Uniphar for GCC distribution of Agamree appeared first on Pharmaceutical Business review....
|
|
|
|
|